Smart card platform vendor CardLogix has partnered with Innovonics, a provider of encryption hardware, to develop and market a smart card/reader product that enables users to access patient records and to make payments through a single desktop terminal.
Smart card platform vendor CardLogix has partnered with Innovonics, a provider of encryption hardware, to develop and market a smart card/reader product that enables users to access patient records and to make payments through a single desktop terminal. Encryption technology secures the transactions themselves, and access to card data is restricted by mutual authentication, which verifies patient identity and user identity to safeguard privacy and protect against fraud. The smart card stores and synchronizes data from medical records, a central database, and patient benefits status.
The combination of Innovonics PC Pay device and the CardLogix multifunction smart card platform enables clinicians as well as insurers to update medical records and process payments. In addition, clients can install the prescription application, which loads onto the card prescriptions that are then filled by an authorized pharmacy. The new product can also be integrated with installed computer systems through the Innovonics PC Pay developer kit, which includes two PC Pay devices, five smart cards, interface software, documentation, and the CardLogix Winplex API. The companies are marketing the developer kits for $789 each.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.